A new version of St. Jude Medical's Epicor LP Cardiac Ablation System has received FDA clearance and CE Mark approval, allowing its sale in the U.S. and Europe. The device, which uses high-intensity focused ultrasound to treat atrial fibrillation, eliminates the need for a heart-lung bypass machine, the company said.

Full Story:

Related Summaries